Welcome to our dedicated page for Marex Group plc SEC filings (Ticker: MRX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Commodity spreads, derivative exposures and multi-jurisdiction capital rules make Marex Group plc’s disclosures dense reading. If you’ve ever searched “where to find Marex Group quarterly earnings report 10-Q filing” or wondered about “Marex Group insider trading Form 4 transactions,” you know the challenge. Each 10-K spans hundreds of pages detailing liquidity provision, clearing risk and segment performance across energy, metals and agricultural markets—data traders, hedge funds and corporate treasurers can’t ignore.
Stock Titan turns that complexity into clarity. Our AI-powered summaries translate VaR tables, regulatory-capital notes and hedging footnotes into plain language so you can understand Marex Group SEC documents with AI in minutes, not hours. Real-time alerts surface Marex Group Form 4 insider transactions, while instant tagging links every Marex Group 8-K material events explained to its exact page reference. You’ll also find the Marex Group proxy statement executive compensation details and the Marex Group annual report 10-K simplified for quick comparison.
Whether you need Marex Group earnings report filing analysis to gauge trading-revenue trends or want to track Marex Group executive stock transactions Form 4 before commodity price swings, every document appears here the moment EDGAR updates. Drill into segment notes directly from your dashboard, export cash-flow tables, or set custom watchlists for new 10-Q or 8-K releases. Investors, analysts and risk officers finally have a single view of Marex Group SEC filings explained simply—powered by AI and ready whenever markets move.
Marex Group has filed a Form 144 notice for the proposed sale of 210,000 shares of common stock through J.P. Morgan Securities, with an aggregate market value of $8,219,400. The sale is scheduled for June 23, 2025, on the Nasdaq exchange.
The securities to be sold were acquired through multiple compensation grants:
- May 2024: 29,243 shares total
- March 2025: 105,122 shares total
- May 2025: 75,635 shares
The total shares outstanding are 71,231,706. The proposed sale represents approximately 0.29% of outstanding shares. No securities were reported sold by the filer during the past three months. This Form 144 filing indicates insider's intention to sell while affirming no knowledge of undisclosed material adverse information about the company.
FAQ
What is the current stock price of Marex Group plc (MRX)?
What is the market cap of Marex Group plc (MRX)?
What is the core business of Marex Group plc?
Which key segments does Marex operate in?
How does Marex enhance market liquidity?
Who are the primary clients of Marex Group plc?
What differentiates Marex from its competitors?
What types of markets does Marex serve?
How does Marex manage regulatory and technological complexities?
